Response to DHSC Coronavirus vaccine regulation consultation

We have submitted the following organisational response to the Distributing vaccines and treatments for COVID-19 and flu consultation run by the Department of Health and Social Care.

1. Temporary authorisation of the supply of unlicensed products

Noting that under normal circumstances vaccines and medications would need to undergo the requisite licensing processes that are detailed in the preamble of the consultation document, in the current climate there is a need to roll-out an effective mass vaccination programme at the earliest available opportunity. Recognising the tension between the benefits of rolling out a mass vaccination programme and the benefits that may bring versus the time it would take to undergo the licensing programme (which may identify unanticipated side effects of the vaccination), and the point made regarding the distinction between unlicensed and untested, on balance the proposed changes to the regulations are welcome in that they are aimed at reducing the exposure of civil liability to both the vaccine manufacturer and those that administer the vaccination (which include non-healthcare professionals on the general practice team). Any such authorisation should be communicated to practitioners including GPs and their teams directly, and via amendments to existing guidance in relation to prescribing unlicensed treatments, such as the GMC guidance here.

2. Civil liability and immunity

The issue with prescribing an unlicensed treatment or vaccine is that if an adverse incident ensues, it is unlikely that there will be any recourse to the manufacturer in relation to product liability (on the basis that the manufacturer will say that the treatment or vaccine was being used outside its licensed indication. The proposed changes to the regulations are welcome in that they are aimed at reducing the exposure of civil liability to both the vaccine manufacturer and those that administer the vaccination (which include non-healthcare professionals on the general practice team). Whilst we note that there are some limits to the extent of the immunity to civil liability but these are in the main directed at the manufacturer and do not seem to be unreasonable.

Given the unique circumstances under which the Covid vaccine may be brought into use, we welcome proposals to limit breach liability to parts of a supply chain which includes the person administering the product, rather than the chain in its entirety.

3. Proposed expansion to the workforce eligible to administer vaccinations

We agree that an expanded workforce is required to deliver a both the Covid and flu vaccination programmes and would highlight the fact that any person who administers any vaccination should have had adequate training and/or updating to cover the following as a minimum:

  • An understanding of the mode of action and efficacy of the vaccine.
  • Explaining the benefits and risks of the vaccine to patients.
  • Explaining the potential side effects of the vaccine and what the patient should do if they occur.
  • Safe vaccine administration (including the cold chain supply).
  • How to manage immediate post vaccine complications (for example – fainting, anaphylaxis etc).
  • Record-keeping.
  • Aftercare.Vaccine promotion.

4. Vaccination promotion

N/A

5. Make provisions for wholesale dealing of vaccines

We welcome the proposal of providing an exemption from the need for a wholesale dealer’s licence to allow the swift and safe transfer of Covid-19 and flu vaccines to be made available to NHS organisations, NHS contracted service providers, and the medical services of the armed forces. For the avoidance of any doubt in relation to the contractual arrangements, we suggest that it would be helpful to specifically confirm that this would apply to Primary Care Networks, Federations and other general practice groups.

Last updated : 22 Sep 2020

 

Tips of the month June 2019 (19 Jun 2019)

We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...
Read more »

PCN Model Schedules update (19 Jun 2019)

We will shortly be issuing an updated version of our PCN Model Schedules to reflect new information which has become available, and respond to queries from practices. The updates include...
Read more »

Babylon GP at Hand update June 2019 (19 Jun 2019)

At the end of May we became aware that Babylon GP at Hand had submitted an application to become a Primary Care Network (PCNs) in Hammersmith and Fulham, with the...
Read more »

Top tips for travel health (18 Jun 2019)

This month Jane Chiodini shares some advice on managing travel health. Jane is a specialist nurse in travel medicine and last October became the first nurse to become Dean...
Read more »

New GP State of Emergency resources (18 Jun 2019)

Thank you to everyone who attended the popular GP State of Emergency (GPSOE) workshop at our annual conference in March, run by Dr Elliott Singer, the Medical Director leading on GPSOE...
Read more »

Migration Advisory Committee calls for GPs to be added to the Shortage Occupation List (14 Jun 2019)

At the end of May the Migration Advisory Committee (MAC) recommended that the Government add all medical practitioner roles to the Shortage Occupation List (SOL). Being on the SOL means...
Read more »

June 2019 workforce survey – thank you for responding (14 Jun 2019)

Our latest workforce survey officially closed on Tuesday 18 June, but we are allowing those who have opened the email to complete the survey, so please do so if you have the...
Read more »
Next Page »
« Previous Page